68Ga-FAPI(Meander Medical Center)

N/A

Report date: 2025/11/18 17:45:24

Base Information

Drug Name68Ga-FAPI(Meander Medical Center)

Drug Alias Name68Ga-FAPI

ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionFibroblast activation protein alpha binders

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesMeander Medical Center

China Registration ClassN/A

Develop Information

Active CompaniesMeander Medical Center

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell Lung

Inactive IndicationsN/A

Other Information

ATC CodeN/A